360 Spotlight: IN8BIO (INAB)

<p>IN8BIO (INAB) is a clinical-stage biopharmaceutical company focused on therapies for the treatment of cancers. William Ho, President, CEO, and Co-Founder of IN8BIO, discusses the company and how IN8BIO went public via IPO on July 30th. He also talks about how IN8BIO develops gamma-delta T-cell therapies for the treatment of cancer. Tune in to find out more.</p><p><br></p>